psychiatric therapies. With more than 20 years of experience in drug discovery, and inflammation and metabolic diseases, Srivastava maintains primary emphasis in medicinal and peptide chemistry. He is a frequently cited journal author, a councilor of the San Diego section of the American Chemical Society, and a two-time recipient of the section's Outstanding Service Award.
Srivastava earned a doctoral degree in organic chemistry from the University of Lucknow in India. Post-doctoral appointments included posts at the University of Georgia and the medical school at the University of Colorado, working under John Stewart, Ph.D.
"These individuals will serve as invaluable resources to NEP and its customers," says Robinson, "bringing depth of experience, industry knowledge and practical perspective to NEP." The backgrounds and leadership styles of each, he continues, "perfectly complement NEP's focus on quality, service and culture of continuous improvement."
About New England Peptide (www.newenglandpeptide.com)
New England Peptide, founded in 1998, designs and produces custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, Mass., the company's chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications.
Peptides are small proteins that play key roles in biochemical regulation of all life systems, helping to fight diseases as diverse as cancer, diabetes, obesity and HIV/AIDS. Peptides' inherent low toxicity and high potency, coupled with improved drug delivery methods and enhanced manufacturing capabilities, are fueling a surge in research and clinical use. All segments of the peptide market - from therapeutics and vaccines to diagnostics and cos
Page: 1 2 3 4 Related biology technology :1
Copyright©2008 Vocus, Inc.
All rights reserved
. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.2
. New England Peptide Names Director of Chemical Development3
. New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration4
. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability5
. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center6
. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:7
. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England8
. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.9
. Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure10
. Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.11
. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress